Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 7/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.56 |
| ▸ | CCR1 | P32246 | 2/20 | 0.56 |
| ▸ | CCR5 | P51681 | 2/20 | 0.56 |
| ▸ | CCR8 | P51685 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | POLB | P06746 | 1/20 | 0.56 |
| ▸ | METAP1 | P53582 | 1/20 | 0.56 |
| ▸ | BLM | P54132 | 1/20 | 0.56 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.56 |
| ▸ | DOHH | Q9BU89 | 1/20 | 0.56 |
| ▸ | P4HTM | Q9NXG6 | 1/20 | 0.56 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.55 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.50 |
| ▸ | GRM5 | P41594 | 2/20 | 0.49 |
| ▸ | RAB9A | P51151 | 7/20 | 0.48 |
| ▸ | NPC1 | O15118 | 6/20 | 0.48 |
| ▸ | TP53 | P04637 | 5/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 5/20 | 0.48 |
| ▸ | PKM | P14618 | 3/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31618896 | 0.98 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL30392773 | 0.98 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL29986091 | 0.98 | KDM4E (0.54) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL5362308 | 0.96 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL858806 | 0.88 | KDM4E (0.72) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL27992763 | 0.87 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL11910216 | 0.87 | KDM4E (0.52) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL11910166 | 0.86 | KDM4E (0.56) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL9952329 | 0.86 | SMN1; SMN2 (0.67) | KDM4ELMNACCR1CCR5CCR8 | |
| SCHEMBL5951032 | 0.86 | GRM5 (0.50) | KDM4ELMNACCR1CCR5CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 598 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260013321-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2026-01-08 | — | — | US | claimed |
| CN-119219634-A | Compound taking azafluoranthene aza five-membered ring as parent nucleus and application thereof | 西安瑞联新材料股份有限公司 | 2024-12-31 | — | — | CN | claimed |
| CN-118515608-A | Synthesis method of palladium-catalyzed aza-ortho-terphenyl hydrocarbon | 新疆大学 | 2024-08-20 | — | — | CN | claimed |
| CN-113871540-B | Organic electroluminescent device and application thereof | 江苏三月科技股份有限公司 | 2024-04-19 | — | — | CN | claimed |
| CN-116178323-A | Aromatic amine organic compound, mixture, composition and organic electronic device | 广州华睿光电材料有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115819413-A | Carbazole-based small-molecule compound, method and organic all-optical synapse based on illumination history-dependent fluorescence intensity mechanism | 中国科学院大学 | 2023-03-21 | — | — | CN | claimed |
| CN-113004194-B | Circular polarization luminescent organic micro-nano crystal material and preparation method and application thereof | 中国科学院化学研究所 | 2022-12-09 | — | — | CN | claimed |
| CN-115403596-A | Oxazine-containing compound, organic light-emitting device and display or lighting device | 安徽省华显新材料科技有限公司 | 2022-11-29 | — | — | CN | claimed |
| CN-112920109-B | Dark blue light-emitting organic micro-nano crystal material and preparation method thereof | 中国科学院化学研究所 | 2022-11-08 | — | — | CN | claimed |
| CN-115141216-A | Oxazine-containing compound and organic light-emitting device thereof | 宇瑞(上海)化学有限公司 | 2022-10-04 | — | — | CN | claimed |
| CN-111952464-A | OLED device based on xanthone compound | 江苏三月光电科技有限公司 | 2020-11-17 | — | — | CN | claimed |
| CN-109574989-B | Compound with dibenzo six-membered ring as core and application thereof in organic electroluminescent device | 中节能万润股份有限公司 | 2020-11-03 | — | — | CN | claimed |
| CN-111747951-A | Triazine compound and organic light-emitting device thereof | 浙江华显光电科技有限公司 | 2020-10-09 | — | — | CN | claimed |
| CN-111689960-A | Triazine compound and organic light-emitting device thereof | 浙江华显光电科技有限公司 | 2020-09-22 | — | — | CN | claimed |
| US-20200274077-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS | SONY CORPORATION (JP) | 2020-08-27 | — | — | US | claimed |
| CN-111316459-A | Photoelectric conversion element and imaging device | 索尼公司 | 2020-06-19 | — | — | CN | claimed |
| CN-111087424-A | Organic compound, organic semiconductor layer, and organic electronic device | 诺瓦尔德股份有限公司 | 2020-05-01 | — | — | CN | claimed |
| US-5422037-A | For electro-optical and display devices | DISPLAYTECH, INC. (US) | 1995-06-06 | — | — | US | claimed |
| CN-1089614-A | Alpha-phosphonosulfonate squalene synthetase inhibitors and method | SQUIBB & SONS INC (US) | 1994-07-20 | — | — | CN | claimed |
| EP-0313338-B1 | Optically active-2-biphenylpyridines | CHISSO CORP (JP) | 1994-03-16 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260013321-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | LBR, GLRA1, GLRB | KDM4E 3102/4885LMNA 406/4885CCR1 229/4885 |
| US-20200274077-A1 | PHOTOELECTRIC CONVERSION ELEMENT AND IMAGING APPARATUS | PPOX, JUP, L1CAM | KDM4E 1764/4885LMNA 3204/4885CCR1 4835/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.